By Mark Durivage
Published in: Cell & Gene
Published on: July 14, 2021
Conclusion Paragraph: Recent changes in the organization, structure, and philosophy at the FDA are a positive sign for the pharmaceutical industry. The guidance contains a comprehensive Appendix that provides several practical examples to help classify the change type, which will be useful for reference and as a training tool when implementing the change assessment and notification process.
